- Bermejo Martin, Jesús F.
- García Mateo, Nadia
- Motos, Anna
- Resino, Salvador
- Tamayo, Luis
- Ryan Murua, Pablo
- Bustamante Munguira, Elena
- Gallego Curto, Elena
- Úbeda Iglesias, Alejandro
- de la Torre, María del Carmen
- Estella García, Ángel
- Campos Fernández, Sandra
- Martínez Varela, Ignacio
- Pérez García, Felipe
- Socias, Lorenzo
- López Messa, Juan
- Vidal Cortés, Pablo
- Sagredo Meneses, Víctor
- González Rivera, Milagros
- Carbonell, Nieves
- de Gonzalo Calvo, David
- Martín Delgado, María Cruz
- Valdivia, Luis Jorge
- Martín López, Caridad
- Jorge García, Ruth Noemí
- Maseda, Emilio
- Loza Vázquez, Ana
- Kelvin, David J.
- Barbé, Ferrán
- Torres, Antoni
- Ortega, Alicia
- de la Fuente, Amanda
- Almansa, Raquel
- Postigo, Tamara
- Jorge, Noelia
- Tedim, Ana P.
- González González, Laura
- Sánchez Recio, Lara
- Trapiello, Wysali
- Berezo, José Ángel
- Herrán Monge, Rubén
- Blanco, Jesús
- Enríquez, Pedro
- Martínez, Isidoro
- Martín Vicente, María
- Muñoz Gómez, María José
- Más, Vicente
- Vázquez, Mónica
- Cano, Olga
- Martínez de la Gándara, Amalia
- Rodríguez, Covadonga
- Andrade, Gloria
- Renedo, Gloria
- Bustamante Munguira, Juan
- Cicuendez Ávila, Ramón
- Salgado Villén, María
- Berruguilla Pérez, Enrique
- Güell, Estel
- Casadiego Monachello, Fernando Javier
- Recuerda Núñez, María
- Sánchez Calvo, Juan Manuel
- Peñasco Martín, Yhivian
- García Unzueta, María Teresa
- Ceccato, Adrián
- Fernández Barat, Laia
- Bouza Vieiro, María Teresa
- Moreno Romero, Ana
- Pérez Bastida, Leire
- del Río Carbajo, Lorena
- Albalá Martínez, Noelia
- Gómez, José Manuel
- Blasco, María Luisa
- Caballero, Jesús
- Barberà, Carme
- González, Jessica
- Nieto, María Teresa
- Nieto del Olmo, Jorge
- Prol Silva, Estefanía
- Canseco Ribas, Joan
- Eiros, Jose María
Background: The contribution of the virus to the pathogenesis of severe COVID-19 is still unclear. We aimed to evaluate associations between viral RNA load in plasma and host response, complications, and deaths in critically ill patients with COVID-19. Methods: We did a prospective cohort study across 23 hospitals in Spain. We included patients aged 18 years or older with laboratory-confirmed SARS-CoV-2 infection who were admitted to an intensive care unit between March 16, 2020, and Feb 27, 2021. RNA of the SARS-CoV-2 nucleocapsid region 1 (N1) was quantified in plasma samples collected from patients in the first 48 h following admission, using digital PCR. Patients were grouped on the basis of N1 quantity: VIR-N1-Zero ([removed]2747 N1 copies per mL). The primary outcome was all-cause death within 90 days after admission. We evaluated odds ratios (ORs) for the primary outcome between groups using a logistic regression analysis. Findings: 1068 patients met the inclusion criteria, of whom 117 had insufficient plasma samples and 115 had key information missing. 836 patients were included in the analysis, of whom 403 (48%) were in the VIR-N1-Low group, 283 (34%) were in the VIR-N1-Storm group, and 150 (18%) were in the VIR-N1-Zero group. Overall, patients in the VIR-N1-Storm group had the most severe disease: 266 (94%) of 283 patients received invasive mechanical ventilation (IMV), 116 (41%) developed acute kidney injury, 180 (65%) had secondary infections, and 148 (52%) died within 90 days. Patients in the VIR-N1-Zero group had the least severe disease: 81 (54%) of 150 received IMV, 34 (23%) developed acute kidney injury, 47 (32%) had secondary infections, and 26 (17%) died within 90 days (OR for death 0·30, 95% CI 0·16–0·55; p<0·0001, compared with the VIR-N1-Storm group). 106 (26%) of 403 patients in the VIR-N1-Low group died within 90 days (OR for death 0·39, 95% CI 0·26–0·57; p[removed], 11 páginas